Universal Vision Biotechnology Co., Ltd. announced the change of the principal financial and accounting officer of the Company. Name, title, and resume of the previous position holder: Principle financial and accounting officer: Sophia Lien (Substitute); Name, title, and resume of the new position holder: Principle financial and accounting officer: Cindy Sun, vice president of financial department of Grand Pacific Investment & Development Co., Ltd.; senior financial manager of Chailease Finance; and assurance services manager of PricewaterhouseCoopers Taiwan; Reason for the change: Position adjustment; Effective date is October 20, 2022.
Universal Vision Biotechnology Co., Ltd.
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
243.5 TWD | 0.00% |
|
-3.37% | -12.09% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.09% | 64Cr | |
+22.00% | 4.47TCr | |
-5.71% | 1.79TCr | |
-30.03% | 195.28Cr | |
+11.49% | 184.59Cr | |
+22.32% | 116.82Cr | |
+70.82% | 66Cr | |
-44.53% | 63Cr | |
-48.16% | 60Cr | |
+31.11% | 54Cr |
- Stock Market
- Equities
- 3218 Stock
- News Universal Vision Biotechnology Co., Ltd.
- Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes